XML 82 R68.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Jun. 14, 2023
Jun. 10, 2021
Jun. 15, 2020
May 14, 2019
May 15, 2018
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Unrecognized compensation cost $ 0.4            
Cost recognized over a weighted-average period 1 year 9 months 18 days            
Equity Stock Awards [Member] | Granted Under 2018 Plan and 2007 Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Common stock, reserved for future issuance 768,731            
Inducement Awards [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Common stock, reserved for future issuance 294,751            
Stock Options and Restricted Stock Awards [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share based compensation $ 0.8 $ 2.7          
Stock Options and Restricted Stock Awards [Member] | Research and Development Expense [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share based compensation 0.2 0.9          
Stock Options and Restricted Stock Awards [Member] | General and Administrative Expense [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share based compensation $ 0.6 $ 1.8          
2018 Stock Incentive Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share-based payment award, shares authorized             180,000
Shares available for issuance 1,206,342            
Stock options, strike price description Options are generally granted with strike prices equal to the fair market value of a share of Imunon common stock on the date of grant. Incentive stock options may be granted to purchase shares of common stock at a price not less than 100% of the fair market value of the underlying shares on the date of grant, provided that the exercise price of any incentive stock option granted to an eligible employee owning more than 10% of the outstanding stock of Imunon must be at least 110% of such fair market value on the date of grant. Only officers and key employees may receive incentive stock options.            
Common stock, reserved for future issuance 1,975,073            
2018 Stock Incentive Plan [Member] | Minimum [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Shares available for issuance     1,030,000 513,333 166,667 80,000  
2018 Stock Incentive Plan [Member] | Maximum [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Shares available for issuance     1,970,000 940,000 426,667 260,000  
Inducement Option Grants [Member] | Five New Employees [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Exercise price per share $ 1.59            
Inducement Option Grants [Member] | Five New Employees [Member] | Restricted Stock [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Restricted stock 91,350            
Inducement Option Grants [Member] | Five New Employees [Member] | Common Stock [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Restricted stock 294,751